| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-10 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-09 |